Based at DCU Invent, Deciphex has gained investors including Inova and GI Partners as it looks to refine its offering for the toxicologic and gastrointestinal segments of pathology.
Oxford Brain Diagnostics hopes to commercialise an early diagnosis tool for Alzheimer’s disease pioneered through eight years of University of Oxford research.
The follow-on investment complements $1.7m raised by Oxford data analytics spinout Mind Foundry in 2016 from investors including Oxford Sciences Innovation.
The total raised by Oxford’s spinouts was down from $229m year-on-year, though university tech transfer office OUI also marked its largest ever single exit during the period.
Victor Christou has stepped down from his position as chief executive of Cambridge Innovation Capital just weeks after helping the unit raise $196m in additional funding.
Gyroscope Therapeutics, spun out of Cambridge and Syncona, has merged with Orbit Biomedical to form a fully-integrated retinal gene therapy developer.
Cambridge Innovation Capital and Parkwalk Advisors have both returned to back a $32.6m series B round for Cytora, an insurance technology spinout of Cambridge.
Chalmers Ventures has contributed to a $1.5m funding round for cleantech developer Metry.